Industry and Physician Collaboration


Collaboration with a focus on the future. Today's panel summarizes the ongoing concerns of the IAGS related to lack of reimbursement for therapies with proven benefit. How can the IAGS, SCAI and industry better collaborate with CMS and the FDA to broaden coverage? This meeting, because of our collaboration with industry and the regulatory agencies, is a productive starting point toward our shared goal of improving care of patients with coronary and peripheral artery disease.